Showing results (1141-1150 of 1,200) with videos related to
Sort By:
Pageof 120
The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.Molecular Cell|December 24, 2003
Assigning function to yeast proteins by integration of technologiesTony R Hazbun, Lars Malmström, Scott Anderson, et al.Journal of Neuroendocrinology|October 20, 2021
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumoursRodney J Hicks, Clarisse Dromain, Wouter W de Herder, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 1, 2023
In-hospital and Post-discharge Status in COVID-19 Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane OxygenationFilomena Regina Barbosa Gomes Galas, Henrique Mateus Fernandes, André Franci, et al.Cells|January 30, 2021
Spermatogonia Loss Correlates with LAMA 1 Expression in Human Prepubertal Testes Stored for Fertility PreservationMagdalena Kurek, Elisabet Åkesson, Masahito Yoshihara, et al.Prenatal Diagnosis|June 22, 2011
The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromesLisa G Shaffer, Justine Coppinger, S Annie Morton, et al.BMC Cancer|December 8, 2020
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant MelanomaYlva Naeser, Hildur Helgadottir, Yvonne Brandberg, et al.British Journal of Haematology|October 5, 2023
Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working PartiesAnnamária Cseh, Jacques-Emmanuel Galimard, Josu de la Fuente, et al.Haematologica|March 27, 2025
Genetic and clinical characteristics of patients with Shwachman Diamond syndrome with special consideration of treatment with granulocyte-colony stimulating factorSabine Mellor-Heineke, Julia Skokowa, Natali Gerschmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 StudyAngela Lamarca, Maxime Ronot, Salma Moalla, et al.Pageof 120